PCL films and containers are used for food packaging applications because they can prolong shelf life, protect against moisture and oxygen, and reduce food waste. PCL-based bags and packaging materials can be composted after use, offering an environmentally friendly alternative to traditional plastic bags. Also, PCL-based fabrics are used in sportswear, activewear, and outdoor clothing due to their softness, durability, and moisture-wicking properties. Due to their abrasion resistance and ease of cleaning, PCL fibers are used in upholstery fabrics for furniture and automotive interiors.
Furthermore, PCL coatings are used on automotive components, such as interior trim, dashboards, and door panels, to improve scratch resistance, durability, and aesthetic appeal. PCL coatings are applied to building exteriors, roofs, and facades to provide weather resistance, UV protection, and corrosion resistance. Similarly, PCL is utilized to formulate personal care products such as creams, lotions, moisturizers, and cosmetics. PCL exhibits excellent emollient properties, making it suitable for skin care and cosmetic formulations. Formulations based on PCL are mild on the skin and less prone to trigger allergic reactions or irritation, which makes them appropriate for people with reactive or sensitive skin types.
High health expenditure in Australia reflects a strong commitment to healthcare improvement and innovation. The need for advanced medical devices and technologies, coupled with supportive regulatory frameworks and collaborative ecosystems, creates opportunities for the growth of PCL products in Australia. According to the Australian Government data, the country spent an estimated $241.3 billion on health goods and services in 2021–22, an average of approximately $9365 per person. The real growth (adjusted for inflation) in total health spending (recurrent and capital) was 6.0% more than in 2020–21. This was higher than the average yearly growth rate over the decade to 2021–22 (3.4%). Therefore, the expansion of the region’s healthcare sector is propelling the market’s growth.
The China market dominated the Asia Pacific Polycaprolactone Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $214.4 Million by 2030. The Japan market is registering a CAGR of 11.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 12.8% during (2023 - 2030).
Based on Production Method, the market is segmented into Ring Opening Polymerization, and Polycondesation of Carboxylic Acid. Based on Form, the market is segmented into Pellets, Nanosphere, and Microsphere. Based on Application, the market is segmented into Coating & Thermoplastic Polyurethane (TPU), Healthcare, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Corbion N.V.
- Otto Chemie Pvt. Ltd.
- BASF SE
- Perstorp Holding AB (PETRONAS Chemicals Group Berhad)
- Daicel Corporation
- Haihang Industry Co.,Ltd. (Haihang Group)
- Merck KGaA
- Polysciences, Inc.
- Shenzhen Esun Industrial Co., Ltd.
- Shenzhen Polymtek Biomaterial Co., Ltd.
Market Report Segmentation
By Production Method (Volume, Thousand Tonnes, USD Billion, 2019-2030)- Ring Opening Polymerization
- Polycondesation of Carboxylic Acid
- Pellets
- Nanosphere
- Microsphere
- Coating & Thermoplastic Polyurethane (TPU)
- Healthcare
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Corbion N.V.
- Otto Chemie Pvt. Ltd.
- BASF SE
- Perstorp Holding AB (PETRONAS Chemicals Group Berhad)
- Daicel Corporation
- Haihang Industry Co.,Ltd. (Haihang Group)
- Merck KGaA
- Polysciences, Inc.
- Shenzhen Esun Industrial Co., Ltd.
- Shenzhen Polymtek Biomaterial Co., Ltd.
Methodology
LOADING...